Voltarol 12.5 mg Norge - norsk - Statens legemiddelverk

voltarol 12.5 mg

glaxosmithkline consumer aps - diklofenakkalium - tablett, filmdrasjert - 12.5 mg

Voltarol 140 mg Norge - norsk - Statens legemiddelverk

voltarol 140 mg

glaxosmithkline consumer healthcare a/s (1) - diklofenaknatrium - medisinert plaster - 140 mg

Zantac 150 mg Norge - norsk - Statens legemiddelverk

zantac 150 mg

glaxosmithkline as - ranitidinhydroklorid - brusetablett - 150 mg

Zantac 25 mg/ ml Norge - norsk - Statens legemiddelverk

zantac 25 mg/ ml

glaxosmithkline as - ranitidinhydroklorid - injeksjonsvæske, oppløsning - 25 mg/ ml

Zovirax 80 mg/ ml Norge - norsk - Statens legemiddelverk

zovirax 80 mg/ ml

glaxosmithkline as - aciklovir - mikstur, suspensjon - 80 mg/ ml

Shingrix Den europeiske union - norsk - EMA (European Medicines Agency)

shingrix

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vaksiner - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. bruk av shingrix skal være i samsvar med offisielle anbefalinger.

Blenrep Den europeiske union - norsk - EMA (European Medicines Agency)

blenrep

glaxosmithkline (ireland) limited - belantamab mafodotin - multippelt myelom - antineoplastiske midler - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Jemperli Den europeiske union - norsk - EMA (European Medicines Agency)

jemperli

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Anoro Ellipta (previously Anoro) Den europeiske union - norsk - EMA (European Medicines Agency)

anoro ellipta (previously anoro)

glaxosmithkline (ireland) limited - umeclidinium bromide, vilanterol trifenatate - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - anoro ellipta er angitt som en vedlikehold bronkodilaterende behandling for å lindre symptomer hos voksne pasienter med kronisk obstruktiv lungesykdom (kols).

Laventair Ellipta (previously Laventair) Den europeiske union - norsk - EMA (European Medicines Agency)

laventair ellipta (previously laventair)

glaxosmithkline (ireland) limited - umeclidinium bromide, vilanterol - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - laventair ellipta er angitt som en vedlikehold bronkodilaterende behandling for å lindre symptomer hos voksne pasienter med kronisk obstruktiv lungesykdom (kols).